AXL and ovarian cancer: In mesenchymal subtype ovarian cancer cell lines, crosstalk between GAS6 activation of AXL and receptor tyrosine kinases (HER2 and MET) and its downstream signalling served specifically to enable cell mobility in mesenchymal cells, a feature absent from other molecular subtypes.